Cargando…

Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease

We report herein the straightforward two-step synthesis and biological assessment of novel racemic benzochromenopyrimidinones as non-hepatotoxic, acetylcholinesterase inhibitors with antioxidative properties. Among them, compound 3Bb displayed a mixed-type inhibition of human acetylcholinesterase (I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dgachi, Youssef, Bautista-Aguilera, Oscar M., Benchekroun, Mohamed, Martin, Hélène, Bonet, Alexandre, Knez, Damijan, Godyń, Justyna, Malawska, Barbara, Gobec, Stanislav, Chioua, Mourad, Janockova, Jana, Soukup, Ondrej, Chabchoub, Fakher, Marco-Contelles, José, Ismaili, Lhassane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273488/ https://www.ncbi.nlm.nih.gov/pubmed/27187348 http://dx.doi.org/10.3390/molecules21050634

Ejemplares similares

Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
por: Dgachi, Youssef, et al.
Publicado: (2018)

N-Hydroxy-N-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases
por: Bautista-Aguilera, Óscar M., et al.
Publicado: (2022)

Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta
por: Hebda, Michalina, et al.
Publicado: (2016)

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′s Disease Therapy
por: Boulebd, Houssem, et al.
Publicado: (2016)

Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer’s Disease Therapy
por: Zribi, Lazhar, et al.
Publicado: (2020)

Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca(2+) Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation
por: Malek, Rim, et al.
Publicado: (2022)

Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents
por: Panek, Dawid, et al.
Publicado: (2018)

Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties
por: Choura, Emna, et al.
Publicado: (2022)

Synthesis of Hantzsch Adducts as Cholinesterases and Calcium Flux inhibitors, Antioxidants and Neuroprotectives
por: Pachón Angona, Irene, et al.
Publicado: (2020)

Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids
por: Bautista-Aguilera, Oscar M, et al.
Publicado: (2014)

Dual Action of Dipyridothiazine and Quinobenzothiazine Derivatives—Anticancer and Cholinesterase-Inhibiting Activity
por: Jończyk, Jakub, et al.
Publicado: (2020)

Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
por: Chrienova, Zofia, et al.
Publicado: (2022)

Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer’s Disease Therapy
por: Bautista-Aguilera, Óscar M., et al.
Publicado: (2020)

Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment
por: Dakhlaoui, Imen, et al.
Publicado: (2023)

QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer’s Disease Therapy
por: Ramos, Eva, et al.
Publicado: (2019)

Screening of Big Pharma’s Library against Various in-house Biological Targets
por: Knez, Damijan, et al.
Publicado: (2022)

Cholinesterase Research
por: Korabecny, Jan, et al.
Publicado: (2021)

Biological Evaluation of Valeriana Extracts from Argentina with Potent Cholinesterase Inhibition for the Treatment of Neurodegenerative Disorders and Their Comorbidities—The Case of Valeriana carnosa Sm. (Caprifoliaceae) Studied in Mice
por: Marcucci, Carolina, et al.
Publicado: (2023)

Guanidines: Synthesis of Novel Histamine H(3)R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect
por: Staszewski, Marek, et al.
Publicado: (2023)

Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors
por: Svobodova, Barbora, et al.
Publicado: (2019)

Structure-Based Search for New Inhibitors of Cholinesterases
por: Bajda, Marek, et al.
Publicado: (2013)

4-Phenethyl-1-Propargylpiperidine-Derived Dual Inhibitors of Butyrylcholinesterase and Monoamine Oxidase B
por: Mazej, Tjaša, et al.
Publicado: (2021)

Polyfunctionalized α-Phenyl-tert-butyl(benzyl)nitrones: Multifunctional Antioxidants for Stroke Treatment
por: Diez-Iriepa, Daniel, et al.
Publicado: (2022)

Editorial: Advances in drug discovery for anti-Alzheimer’s agents
por: Ismaili, Lhassane
Publicado: (2022)

8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases
por: Knez, Damijan, et al.
Publicado: (2023)

Design, Synthesis and Biological Evaluation of New Antioxidant and Neuroprotective Multitarget Directed Ligands Able to Block Calcium Channels
por: Pachòn Angona, Irene, et al.
Publicado: (2020)

Chromenones as Multineurotargeting Inhibitors of Human Enzymes
por: Lemke, Carina, et al.
Publicado: (2019)

Fragment-Sized Thiazoles in Fragment-Based Drug Discovery Campaigns: Friend or Foe?
por: Proj, Matic, et al.
Publicado: (2022)

Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells
por: Hudáčová, Monika, et al.
Publicado: (2021)

ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy
por: Marco-Contelles, José, et al.
Publicado: (2016)

Benzophenone Derivatives with Histamine H(3) Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer’s Disease
por: Godyń, Justyna, et al.
Publicado: (2022)

Design, synthesis and evaluation of OA-tacrine hybrids as cholinesterase inhibitors with low neurotoxicity and hepatotoxicity against Alzheimer’s disease
por: Yang, Huali, et al.
Publicado: (2023)

Synthesis and Initial Characterization of a Reversible, Selective (18)F-Labeled Radiotracer for Human Butyrylcholinesterase
por: Gentzsch, Christian, et al.
Publicado: (2021)

In Vitro and In Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases
por: Więckowska, Anna, et al.
Publicado: (2020)

The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy
por: Rodríguez-Ruiz, Emelina R., et al.
Publicado: (2023)

WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors
por: Scarpino, Andrea, et al.
Publicado: (2021)

Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of Necrotic and Apoptotic Cell Death
por: Chamorro, Beatriz, et al.
Publicado: (2023)

Homo-Tris-Nitrones Derived from α-Phenyl-N-tert-butylnitrone: Synthesis, Neuroprotection and Antioxidant Properties
por: Diez-Iriepa, Daniel, et al.
Publicado: (2020)

Postischemic Neuroprotection of Aminoethoxydiphenyl Borate Associates Shortening of Peri-Infarct Depolarizations
por: Fernández-Serra, Rocío, et al.
Publicado: (2022)

5-Amino-3-methyl-1-phenyl-1H-1,2,4-triazole
por: Allouch, Fatma, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_k5prcl926lqkv7mrngvchoh44i